Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy for Proliferative Diabetic Retinopathy

To evaluate the efficacy and safety of anti-vascular endothelial growth factor (VEGF) and panretinal photocoagulation (PRP) for the treatment of proliferative diabetic retinopathy (PDR). The outcomes examined are changes in Best Corrected Visual Acuity (BCVA), Neovascularization (NV), Central Macular Thickness (CMT), and adverse outcomes.